Lavender (Lavandula angustifolia)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Lavandula angustifolia Mill. (syn. Lavandula officinalis Chaix; Lavandula vera DC.)
• Family: Lamiaceae
• Common Name(s): English Lavender, True Lavender, Common Lavender
• Parts Used: Dried flower buds, essential oil distilled from fresh flowering tops.

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: A strongly aromatic, evergreen, multi-branched semi-shrub growing 30 to 90 cm high.
  • Morphology: Leaves are opposite, sessile, linear-lanceolate, entire, with revolute margins, and covered in fine silver-gray tomentose hairs when young. Flowers are bluish-violet, bilabiate, arranged in terminal, interrupted spikes.
• Habitat & Cultivation: Native to the Mediterranean region (France, Spain, Italy). Thrives in dry, sunny, calcareous, well-drained soils. Widely cultivated globally.
• Sustainability Status: Secure; stable globally due to extensive agricultural production.

Energetics & Traditional Actions

• Western Tissue States: Corrects Constriction (wind/tension) and Irritation (heat).
• Traditional Vector:
  • Ayurveda: Rasa (Taste): Tikta (Bitter), Katu (Pungent) | Virya (Energy): Sheeta (Cooling) | Vipaka (Post-Digestive Effect): Katu (Pungent) | Dosha Modulation: Pacifies Vata and Pitta; can aggravate Kapha if overused.
  • Traditional Chinese Medicine: Temperature: Cool | Taste: Spicy, Bitter | Organ Meridians Entered: Heart, Liver, Lung
• Historical Folk Use: Historically utilized in Roman baths for its purifying scent (lavare meaning “to wash”). Used for centuries as a carminative for nervous dyspepsia, a traditional remedy for headaches, and a nervine to dispel grief, anxiety, and insomnia.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Volatile oil (1–3% containing linalyl acetate [30–55%], linalool [20–35%], terpinen-4-ol, lavandulyl acetate), hydroxycoumarins (umbelliferone), flavonoids (luteolin), and phenolic acids (rosmarinic acid).
• Mechanism of Action: > Linalool and linalyl acetate are rapidly absorbed into the bloodstream following inhalation or oral ingestion. They modulate central nervous system activity by interacting with the $\text{GABA}_A$ receptor complex, enhancing GABAergic transmission, and inhibiting voltage-gated calcium channels ($N\text{-type}$ and $P/Q\text{-type}$). This suppresses glutamate release, generating profound anxiolytic, sedative, and spasmolytic outcomes without causing physical dependence.

Clinical Applications & Indications

• Primary Indications: Generalized Anxiety Disorder (GAD), subsyndromal anxiety, sleep onset insomnia, nervous exhaustion, and psychogenic somatization disorders.
• Secondary Indications: Nervous dyspepsia, intestinal flatulence, tension headaches (topical/inhalation), and minor burns or wound healing (essential oil).
• Modern Clinical Evidence: Robust human data demonstrates that a standardized oral lavender oil preparation (e.g., Silexan, 80 mg daily) is clinically non-inferior to low-dose lorazepam and paroxetine in reducing anxiety scores on the Hamilton Anxiety Scale (HAMA), showing high tolerability.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: High ethanol percentages (60–70% EtOH) are necessary to completely extract the volatile monoterpenes and esters. Infusions should always be steeped under a tight lid to prevent the loss of therapeutic volatile oils via steam.

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: Known hypersensitivity to lavender or Lamiaceae family members. Oral essential oil use is contraindicated in children, pregnant women, and lactating mothers due to a lack of safety profiles.
• Side Effects & Toxicity Thresholds: Exceptionally safe as a whole-plant extract. Standardized oral essential oils can occasionally induce mild gastrointestinal burping or minor nausea.
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: Minimal to no clinical impact on CYP450 cascades at standard doses.
  • Additive Pathways: CNS Sedatives: May potentiate the sedative response of benzodiazepines, barbiturates, SSRIs, and alcohol. Monitor patients concurrently taking anxiolytics closely.

References

1. Grieve, M. (1931). A Modern Herbal. Harcourt, Brace & Company.
2. Kasper, S., et al. (2010). Efficacy and safety of an oral lavender oil preparation (Silexan) in vague anxiety disorder. International Clinical Psychopharmacology, 25(5), 277-287.
3. Bone, K., & Mills, S. (2013). Principles and Practice of Phytotherapy (2nd ed.). Churchill Livingstone.